← Insider buys
RMD

ResMed Inc. · Healthcare

Chief Administrative Officer David Pendarvis sold $387K of ResMed Inc.

Sold$386,957
$250.62Price
1,544Shares
−1%Stake

What RMD did after the filing

Filed Mar 4, copier in the same day
The stock from Fri, Mar 4 open, $247.98
−6.4%
S&P 500, same days
+1.8%

Measured over 30 trading days, to the Apr 18 close.

Traded Thu, Mar 3. Filed Fri, Mar 4, 9:04 AM ET, before the open. Returns use the Mar 4 open and the Apr 18 close. Not investment advice.